Biomet Profile (Large Joints): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials 2012

October 2011 | 65 pages | ID: B0DCD02A113EN
iData Research Inc.

Abstracts

Biomet is one of the five largest orthopedic implant manufacturers in the world, with distribution in the U.S., Europe, Asia and a number of emerging markets. Throughout its history, the company has also expanded into areas such as sports medicine and dental medical devices. As of 2011, Biomet distributed products in approximately 90 countries across the globe, earning revenues in the billions. This report is a comprehensive overview of Biomet's business activities with an in-depth analysis of the company's market share and presence in global orthopedic large joint reconstructive device markets.

The information covered includes:

• An overview of the company history and current product divisions
• A summary of corporate financial metrics
• A review of recently approved products and the results of preliminary clinical trials
• An in-depth review of the strengths, weaknesses opportunities and threats (SWOT) to the company's orthopedic biomaterials divisions
• A detailed look at the market share and performance of each division in various countries across the U.S., Europe and Asia. Whenever possible, market share and division revenues are examined by individual country for each region of the globe.

The key product areas covered in this report include:

• Hip Reconstruction
• Knee Reconstruction

The countries covered in this report include:

• U.S.
• Germany
• France
• U.K.
• Spain
• Italy
• Benelux
• Scandinavia
• Switzerland
• Austria
• Portugal
• Japan
• Australia
• South Korea

Contents

EXECUTIVE SUMMARY

1.1 BIOMET OVERVIEW
1.2 CORPORATE REVENUE GROWTH BY BUSINESS UNIT
1.3 GLOBAL REVENUE BY REGION
1.4 GLOBAL MARKET SHARE BY MARKET SIZE
1.5 MARKET SHARE: LARGE JOINT RECONSTRUCTION

RESEARCH METHODOLOGY

2.1 IDATA’S 9-STEP METHODOLOGY
  2.1.1 Step 1: Project Initiation & Team Selection
  2.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
  2.1.3 Step 3: Preparation for Interviews & Questionnaire Design
  2.1.4 Step 4: Performing Primary Research
  2.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
  2.1.6 Step 6: Market Forecast and Analysis
  2.1.7 Step 7: Identify Strategic Opportunities
  2.1.8 Step 8: Final Review and Market Release
  2.1.9 Step 9: Customer Feedback and Market Monitoring

BIOMET COMPANY OVERVIEW

3.1 INTRODUCTION
3.2 COMPANY PROFILE
  3.2.1 Business Units
    3.2.1.1 Orthopedic Reconstruction
    3.2.1.2 Orthopedic Trauma, Spine and Biologics
    3.2.1.3 Sports Medicine
    3.2.1.4 Craniomaxillofacial
    3.2.1.5 Dental
3.3 GLOBAL REVENUES
  3.3.1 Global Revenues by Division
  3.3.2 Global Revenues by Geography
3.4 COMPANY HISTORY
3.5 COMPANY INFORMATION
  3.5.1 Size
  3.5.2 Office and Facility Locations

FINANCIAL METRICS

4.1 INCOME STATEMENT
4.2 BALANCE SHEET
  4.2.1 Balance Sheet
  4.2.2 Company Debt

PRODUCT PIPELINE

5.1 LARGE JOINT RECONSTRUCTION
  5.1.1 U.S. FDA Investigational Device Exemption (IDE)
  5.1.2 U.S. FDA Trials
  5.1.3 International Trials
    5.1.3.1 Oxford Partial Knee using Signature Custom Guides and Conventional
Instrumentation
  5.1.4 U.S. FDA 510(k) Approvals
    5.1.4.1 Active Articulation E1
    5.1.4.2 Signature™ Personalized Patient Care System
    5.1.4.3 Vanguard™ Knee Prosthesis
    5.1.4.4 Taperloc™ Hip Replacement
  5.1.5 U.S. FDA PMA Approval Updates
    5.1.5.1 Oxford™ Partial Knee

SWOT ANALYSIS

6.1 LARGE JOINT RECONSTRUCTION SWOT ANALYSIS
  6.1.1 Strengths
  6.1.2 Weaknesses
  6.1.3 Opportunities
  6.1.4 Threats
    6.1.4.1 Troubled Global Economy

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS

7.1 MARKET INTRODUCTION
  7.1.1 Knee Reconstruction
    7.1.1.1 Anatomy
    7.1.1.2 Pathology
    7.1.1.3 Implant Types
      7.1.1.3.1 Total Knee Replacement
      7.1.1.3.2 Partial Knee Replacement
      7.1.1.3.3 Patellofemoral Replacement
      7.1.1.3.4 Interpositional Knee Implants
      7.1.1.3.5 Knee Revision
    7.1.1.4 Fixation Method
    7.1.1.5 Bearing Surface
    7.1.1.6 Fixed verses Mobile Bearings
  7.1.2 Hip Reconstruction
    7.1.2.1 Anatomy
    7.1.2.2 Pathology
    7.1.2.3 Treatment
    7.1.2.4 Implant Types
      7.1.2.4.1 Total Hip Joint Replacement
      7.1.2.4.2 Partial Hip Joint Replacement
      7.1.2.4.3 Resurfacing Hip Joint Replacement
      7.1.2.4.4 Revision Hip Joint Replacement
    7.1.2.5 Fixation Method
    7.1.2.6 Implant Material
    7.1.2.7 Bearing Surface Technology
      7.1.2.7.1 Polyethylene Bearings
      7.1.2.7.2 Highly Cross-Linked Polyethylene Bearings
      7.1.2.7.3 Metal Bearings
      7.1.2.7.4 Ceramic Bearings
7.2 MARKET SHARE AND REVENUE ANALYSIS
  7.2.1 Combined Large Joint Reconstruction
    7.2.1.1 Global Market Share
    7.2.1.2 U.S. Market Share
    7.2.1.3 European Market Share by Country
    7.2.1.4 Asian Market Share by Country
  7.2.2 Hip Reconstruction
    7.2.2.1 Global Market Share
    7.2.2.2 Asia Pacific Market Share
  7.2.3 Knee Reconstruction
    7.2.3.1 Global
    7.2.3.2 Asia Pacific Market Share

ABBREVIATIONS

List Of Figures

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

BIOMET COMPANY OVERVIEW

Figure 3-1: Global Revenues by Division, Biomet, (US$M), 2010 – 2011
Figure 3-2: Global Revenues Growth by Division, Biomet, 2011
Figure 3-3: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
Figure 3-4: Global Revenues by Geography, Biomet, (US$M), 2010 – 2011
Figure 3-5: Global Revenues by Geography, Biomet, 2011
Figure 3-6: Company Size, Biomet, 2011
Figure 3-7: Key Facilities, Biomet, 2011

FINANCIAL METRICS

Figure 4-1: Income Statement, Biomet, 2009 – 2011 (US$M)
Figure 4-2: Balance Sheet, Biomet, 2009 – 2011 (US$M)
Figure 4-3: Company Debt, Biomet, 2011 (US$M)

PRODUCT PIPELINE

SWOT ANALYSIS

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS

Figure 7-1: Large Joint Reconstruction Market Share, Biomet, 2011 (US$M)
Figure 7-2: Large Joint Reconstruction Market Share, Europe, Biomet, 2011 (US$M)
Figure 7-3: Large Joint Reconstruction Market Share, Asia, Biomet, 2011 (US$M)
Figure 7-4: Hip Reconstruction Market Share, Biomet, 2011 (US$M)
Figure 7-5: Hip Reconstruction Market Share by Country, Europe, Biomet, 2011 (US$M)
Figure 7-6: Hip Reconstruction Market Share by Country, Asia, Biomet, 2011 (US$M)
Figure 7-7: Knee Reconstruction Market Share, Biomet, 2011
Figure 7-8: Hip Reconstruction Market Share, Biomet, 2011
Figure 7-9: Knee Reconstruction Market Share, Biomet, 2011

ABBREVIATIONS

List Of Charts

LIST OF CHARTS

EXECUTIVE SUMMARY

Chart 1-1: Business Unit Revenue by Percentage, Biomet, 2011
Chart 1-2: Annual Revenue Growth by Business Unit, Biomet, 2011
Chart 1-3: Percentage of Global Revenues by Region, Biomet, 2011
Chart 1-4: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
Chart 1-5: Large Joint Reconstruction Market Share, Biomet, 2011

RESEARCH METHODOLOGY

BIOMET COMPANY OVERVIEW

Chart 3-1: Global Revenues by Division, Biomet, 2011
Chart 3-2: Global Revenue Growth by Division, Biomet, 2011
Chart 3-3: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011

FINANCIAL METRICS

PRODUCT PIPELINE

SWOT ANALYSIS

LARGE JOINT RECONSTRUCTION MARKET SHARE ANALYSIS

Chart 7-1: Global Large Joint Reconstruction Market Share, Biomet, 2011 (US$M)
Chart 7-2: Large Joint Reconstruction Market Share by Region, Biomet, 2011 (US$M)
Chart 7-3: Global Hip Reconstruction Market Share, Biomet, 2011
Chart 7-4: Hip Reconstruction Market Share by Region, Biomet, 2011
Chart 7-5: Global Knee Reconstruction Market Share, Biomet, 2011
Chart 7-6: Knee Reconstruction Market Share by Region, Biomet, 2011

ABBREVIATIONS